EGFR and lung carcinoma: The factors related to the enhanced efficacy of immunotherapy in EGFR‐driven lung cancer should be further investigated as it is certain that some patients with EGFR‐mutant lung cancer exhibit a remarkable and durable response to immunotherapy.